Woodruff Prescott G, Boushey Homer A, Dolganov Gregory M, Barker Chris S, Yang Yee Hwa, Donnelly Samantha, Ellwanger Almut, Sidhu Sukhvinder S, Dao-Pick Trang P, Pantoja Carlos, Erle David J, Yamamoto Keith R, Fahy John V
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA.
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15858-63. doi: 10.1073/pnas.0707413104. Epub 2007 Sep 26.
Airway inflammation and epithelial remodeling are two key features of asthma. IL-13 and other cytokines produced during T helper type 2 cell-driven allergic inflammation contribute to airway epithelial goblet cell metaplasia and may alter epithelial-mesenchymal signaling, leading to increased subepithelial fibrosis or hyperplasia of smooth muscle. The beneficial effects of corticosteroids in asthma could relate to their ability to directly or indirectly decrease epithelial cell activation by inflammatory cells and cytokines. To identify markers of epithelial cell dysfunction and the effects of corticosteroids on epithelial cells in asthma, we studied airway epithelial cells collected from asthmatic subjects enrolled in a randomized controlled trial of inhaled corticosteroids, from healthy subjects and from smokers (disease control). By using gene expression microarrays, we found that chloride channel, calcium-activated, family member 1 (CLCA1), periostin, and serine peptidase inhibitor, clade B (ovalbumin), member 2 (serpinB2) were up-regulated in asthma but not in smokers. Corticosteroid treatment down-regulated expression of these three genes and markedly up-regulated expression of FK506-binding protein 51 (FKBP51). Whereas high baseline expression of CLCA1, periostin, and serpinB2 was associated with a good clinical response to corticosteroids, high expression of FKBP51 was associated with a poor response. By using airway epithelial cells in culture, we found that IL-13 increased expression of CLCA1, periostin, and serpinB2, an effect that was suppressed by corticosteroids. Corticosteroids also induced expression of FKBP51. Taken together, our findings show that airway epithelial cells in asthma have a distinct activation profile and identify direct and cell-autonomous effects of corticosteroid treatment on airway epithelial cells that relate to treatment responses and can now be the focus of specific mechanistic studies.
气道炎症和上皮重塑是哮喘的两个关键特征。白细胞介素-13及在2型辅助性T细胞驱动的过敏性炎症过程中产生的其他细胞因子,会导致气道上皮杯状细胞化生,并可能改变上皮-间质信号传导,进而导致上皮下纤维化加重或平滑肌增生。皮质类固醇在哮喘治疗中的有益作用,可能与其直接或间接降低炎症细胞和细胞因子对上皮细胞激活作用的能力有关。为了确定哮喘中上皮细胞功能障碍的标志物以及皮质类固醇对上皮细胞的影响,我们研究了从参加吸入性皮质类固醇随机对照试验的哮喘患者、健康受试者和吸烟者(疾病对照)收集的气道上皮细胞。通过使用基因表达微阵列,我们发现钙激活氯离子通道家族成员1(CLCA1)、骨膜蛋白和丝氨酸蛋白酶抑制剂家族B(卵清蛋白)成员2(丝氨酸蛋白酶抑制剂B2)在哮喘患者中表达上调,但在吸烟者中未上调。皮质类固醇治疗使这三个基因的表达下调,并显著上调FK506结合蛋白51(FKBP51)的表达。虽然CLCA1、骨膜蛋白和丝氨酸蛋白酶抑制剂B2的高基线表达与对皮质类固醇的良好临床反应相关,但FKBP51的高表达与反应不佳相关。通过使用培养的气道上皮细胞,我们发现白细胞介素-13增加了CLCA1、骨膜蛋白和丝氨酸蛋白酶抑制剂B2的表达,这种作用被皮质类固醇抑制。皮质类固醇还诱导了FKBP51的表达。综上所述,我们的研究结果表明,哮喘患者的气道上皮细胞具有独特的激活特征,并确定了皮质类固醇治疗对气道上皮细胞的直接和细胞自主作用,这些作用与治疗反应相关,现在可以成为具体机制研究的重点。